Although amyloidosis is not a rheumatic disease, rheumatologists may be the first to diagnose this life-threatening condition
Search results for: carpal tunnel syndrome
ACR/ARHP Annual Meeting 2012: Use a Combination of Tests, Patient History, and Physical Exam when Assessing Myopathies
Autoantibody testing, electromyogram, muscle tissue biopsy, and a clinical exam may help confirm a myopathy diagnosis
Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection
Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously
Nomenclature, Semantics, Jargon, Lingo, Eponyms, Etymology, and Terminology in Rheumatology
Why rheumatologists must coin simple, comprehensible terms for what we read, speak and write to our patients
The Clinician’s Role in Rehabilitation Therapy
Learn when and how to refer a patient to a physical or occupational therapist or other specialist
If the Best You Can Do Is Zero
When we focus on loss, do we hurt our chances for gain?
Rheumatology Stakeholders Talk Quality
ACR urged to accelerate efforts to develop quality indicators
Genes Connect Parkinson’s Disease to Autoimmune Diseases
A study has identified several common genetic pathways between Parkinson’s disease and autoimmune diseases. Specifically, researchers have used a genome-wide conjunctional analysis to identify 17 novel loci that overlap the conditions…
Parkinson’s, Autoimmune Disorders May Share Genetic Common Ground
NEW YORK (Reuters Health)—Parkinson’s disease and some autoimmune diseases may have genetic risk factors in common, raising the possibility that the immune system may influence Parkinson’s disease pathogenesis, new research suggests. The study, which analyzed data from genome-wide association studies, “showed a considerable genetic overlap between [Parkinson’s disease] and autoimmune diseases, in particular, type 1…
Women on Osteoporosis Drugs Still Need Bone Density Screenings
(Reuters Health)—Women with osteoporosis who take bisphosphonates to help avoid fractures still need to have their bone density monitored, a Canadian study suggests. Researchers who studied more than 6,600 women taking osteoporosis drugs found that for nearly one in five, bone mineral density at the hip actually decreased after the women started taking the medication….